![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Applications:
Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer
Category: Controlled & Modified Release
Technical Specifications: Available as powder; Other grades- EUDRAGIT® L 30 D-55
Applications:
Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form: Tablet
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form: Tablet
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer
Category: Controlled & Modified Release
Technical Specifications: NA
Applications:
Enteric, Delayed Release Matrix and Solubility Enhancement
Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer
Category: Controlled & Modified Release
Technical Specifications: Methylacryli acid and Ethyl Acrylate copolymer (1:1) Type A
Applications:
Ingredient(s): Methacrylic Acid & Ethyl Acrylate Copolymer
Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Enteric coating with release above pH 5.5 (partially preneutralized powder)
Ingredient(s): Methacrylic Acid & Ethyl Acrylate Copolymer
Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet
Category: Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Enteric coating with release above pH 5.5 (30 % solids content dispersion)
Ingredient(s): Methacrylic Acid & Ethyl Acrylate Copolymer
Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet
Category: Controlled & Modified Release
Technical Specifications: Not Available